Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jérôme Galon"'
Autor:
Mihaela Angelova, Ralf Gallasch, Hubert Hackl, Jérôme Galon, Pornpimol Charoentong, Zlatko Trajanoski, Mirjana Efremova
Publikováno v:
Cancer Immunology, Immunotherapy
Recent mechanistic insights obtained from preclinical studies and the approval of the first immunotherapies has motivated increasing number of academic investigators and pharmaceutical/biotech companies to further elucidate the role of immunity in tu
Autor:
Roger S. Lo, Bastian Schilling, Francesco M. Marincola, David F. Stroncek, Silvia C. Formenti, Nicola Mozzillo, Rolf Kiessling, Pedro Romero, Sara Tomei, Alistair J. Cochran, Carlo Bifulco, Sandra Demaria, Igor Puzanov, Thomas F. Gajewski, Gennaro Ciliberto, Ena Wang, Grant Mc Arthur, Paul Lorigan, Giorgio Parmiani, Claus Garbe, Hassane M. Zarour, Alessandro Testori, Michael Davies, Gerardo Botti, Soldano Ferrone, Giuseppe Masucci, Janis M. Taube, Magdalena Thurin, Martin C. Mihm, Giuseppe Palmieri, Barbara Seliger, Samir N. Khleif, Paolo A. Ascierto, Reinhard Dummer, Michael B. Atkins, Ignacio Melero, Jérôme Galon
Publikováno v:
Journal of translational medicine, vol 13, iss 1
Journal of Translational Medicine, vol. 13, pp. 374
Journal of translational medicine (Online) (2015). doi:10.1186/s12967-015-0736-1
info:cnr-pdr/source/autori:Ascierto PA, Atkins M, Bifulco C, Botti G, Cochran A, Davies M,? Demaria S, Dummer R, Ferrone S, Formenti S, Gajewski TF, Garbe C, Khleif S, Kiessling R, Lo R, Lorigan P, Mc Arthur G, Masucci G, Melero I, Mihm M, Palmieri G, Parmiani G, Puzanov I, Romero P, Schilling B, Seliger B, Stroncek D, Taube J, Tomei S, Zarour HM, Testori A, Wang E, Galon J, Ciliberto G, Mozzillo N, Marincola F, Thurin M/titolo:Future perspectives in melanoma?research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014/doi:10.1186%2Fs12967-015-0736-1/rivista:Journal of translational medicine (Online)/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of Translational Medicine
Journal of Translational Medicine, vol. 13, pp. 374
Journal of translational medicine (Online) (2015). doi:10.1186/s12967-015-0736-1
info:cnr-pdr/source/autori:Ascierto PA, Atkins M, Bifulco C, Botti G, Cochran A, Davies M,? Demaria S, Dummer R, Ferrone S, Formenti S, Gajewski TF, Garbe C, Khleif S, Kiessling R, Lo R, Lorigan P, Mc Arthur G, Masucci G, Melero I, Mihm M, Palmieri G, Parmiani G, Puzanov I, Romero P, Schilling B, Seliger B, Stroncek D, Taube J, Tomei S, Zarour HM, Testori A, Wang E, Galon J, Ciliberto G, Mozzillo N, Marincola F, Thurin M/titolo:Future perspectives in melanoma?research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014/doi:10.1186%2Fs12967-015-0736-1/rivista:Journal of translational medicine (Online)/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of Translational Medicine
The fourth "Melanoma Bridge Meeting" took place in Naples, December 3-6th, 2014. The four topics discussed at this meeting were: Molecular and Immunological Advances, Combination Therapies, News in Immunotherapy, and Tumor Microenvironment and Biomar
Autor:
Pierre Coulie, Howard L. Kaufman, Jérôme Galon, Lisa H. Butterfield, Francesco M. Marincola, Ira Mellman, Suzanne L. Topalian, Willem W. Overwijk, Samir N. Khleif, Pamela S. Ohashi, Robert L. Ferris, Sandra Demaria
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol. 4, no.1, p. 37 (2016)
Journal for ImmunoTherapy of Cancer, Vol. 4, no.1, p. 37 (2016)
The Common Rule is a set of ethical principles that provide guidance on the management of human subjects taking part in biomedical and behavioral research in the United States. The elements of the Common Rule were initially developed in 1981 followin
Autor:
Helen K. Angell, Tessa Fredriksen, Franck Pagès, Marie Tosolini, Bernhard Mlecnik, Jérôme Galon, Gabriela Bindea, Maximilian J. Waldner, Lucie Lafontaine, Viia Valge-Archer
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer, BMJ Publishing Group 2013, 1 (Suppl 1), pp.P144
Journal for Immunotherapy of Cancer, London : BioMed Central, 2013-, 2013, 1 (Suppl 1), pp.P144
Journal for Immunotherapy of Cancer, 2013, 1 (Suppl 1), pp.P144
Journal for Immunotherapy of Cancer, BMJ Publishing Group 2013, 1 (Suppl 1), pp.P144
Journal for Immunotherapy of Cancer, London : BioMed Central, 2013-, 2013, 1 (Suppl 1), pp.P144
Journal for Immunotherapy of Cancer, 2013, 1 (Suppl 1), pp.P144
Meeting abstracts We have previously defined the immune contexture as the type, density, location and functional orientation of tumour infiltrating immune cells, associated with patient prognosis in colorectal cancer (CRC). Here we describe potential
Autor:
Iris D. Nagtegaal, Paul Waring, Michael I. Nishimura, Richard Palmqvist, Carlo Bifulco, Yutaka Kawakami, Christian H. Ottensmeier, Alessandro Lugli, Christoph Huber, Réjean Lapointe, Lotfi Chouchane, Noriyuki Sato, Helen K. Angell, Scott Kopetz, Kyogo Itoh, Michele Maio, Yili Wang, Bernard A. Fox, Thomas F. Gajewski, Christine Lagorce, Franck Pagès, Cedrik M. Britten, Ena Wang, Giuseppe Masucci, Patricia Shaw, Frank A. Sinicrope, Jill O'Donnell-Tormey, Fabiana Tatangelo, Andreas Lundqvist, Heinz Zwierzina, James P. Allison, Toshihiko Torigoe, P. Patel, Inti Zlobec, Blaise Clarke, Martin Asslaber, Corrado D'Arrigo, Shoichi Hazama, Martin C. Mihm, Harpreet Singh-Jasuja, Luigi Laghi, Anne Berger, Jérôme Galon, Samir N. Khleif, Paolo Delrio, Shilin N. Shukla, Gerardo Botti, Hartmann Arndt, Francesco M. Marincola, Leif Håkansson, Paolo A. Ascierto, Robert E. Hawkins, Bradly G. Wouters, Sacha Gnjatic, Graham Pawelec, Fabio Grizzi, Fernando Vidal-Vanaclocha, Shuji Ogino, Sebastian Kreiter, Kiyotaka Okuno, Peter Gibbs, Magdalena Thurin, Giorgio Trinchieri, Pamela S. Ohashi
Publikováno v:
Galon, Jérôme; Pagès, Franck; Marincola, Francesco M.; Angell, Helen K.; Thurin, Magdalena; Lugli, Alessandro; Zlobec, Inti; Berger, Anne; Bifulco, Carlo; Botti, Gerardo; Tatangelo, Fabiana; Britten, Cedrik M.; Kreiter, Sebastian; Chouchane, Lotfi; Delrio, Paolo; Arndt, Hartmann; Asslaber, Martin; Maio, Michele; Masucci, Giuseppe V.; Mihm, Martin; ... (2012). Cancer classification using the Immunoscore: a worldwide task force. Journal of translational medicine, 10, p. 205. London: BioMed Central 10.1186/1479-5876-10-205
Journal of Translational Medicine, 10. BioMed Central Ltd
Journal of Translational Medicine
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.205. 〈10.1186/1479-5876-10-205〉
Journal of Translational Medicine, 2012, 10 (1), pp.205. ⟨10.1186/1479-5876-10-205⟩
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.205. ⟨10.1186/1479-5876-10-205⟩
Journal of Translational Medicine, Vol 10, Iss 1, p 205 (2012)
Journal of Translational Medicine, 10. BioMed Central Ltd
Journal of Translational Medicine
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.205. 〈10.1186/1479-5876-10-205〉
Journal of Translational Medicine, 2012, 10 (1), pp.205. ⟨10.1186/1479-5876-10-205⟩
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.205. ⟨10.1186/1479-5876-10-205⟩
Journal of Translational Medicine, Vol 10, Iss 1, p 205 (2012)
International audience; Prediction of clinical outcome in cancer is usually achieved by histopathological evaluation of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor staging (AJCC/UICC-TNM classification) s
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts No biomarker has been validated so far to predict the need for adjuvant chemotherapy in Stage II colon cancer (CC), and current guidelines, e.g. NCCN, only rely on the identification of high-risk features such as MSI, pathological t
Autor:
Franck Pagès, Bernard A. Fox, Thomas F. Gajewski, Giorgio Trinchieri, Francesco M. Marincola, Paolo A. Ascierto, Magdalena Thurin, Jérôme Galon
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, 2012, 10 (1), pp.1. ⟨10.1186/1479-5876-10-1⟩
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.1. 〈10.1186/1479-5876-10-1〉
Journal of Translational Medicine, Vol 10, Iss 1, p 1 (2012)
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.1. ⟨10.1186/1479-5876-10-1⟩
Journal of Translational Medicine, 2012, 10 (1), pp.1. ⟨10.1186/1479-5876-10-1⟩
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.1. 〈10.1186/1479-5876-10-1〉
Journal of Translational Medicine, Vol 10, Iss 1, p 1 (2012)
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.1. ⟨10.1186/1479-5876-10-1⟩
The outcome prediction in cancer is usually achieved by evaluating tissue samples obtained during surgical removal of the primary tumor focusing on their histopathological characteristics. Tumor staging (AJCC/UICC-TNM classification) summarizes data
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts Classical methods for determining malignant disease prognosis are based upon characterizing the morphology and location of tumor cells. While this analysis provides important information about a patient's disease it fails to capture